Skip to content
Screener

Wave Life Sciences WVE Cash Flow Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
-$61.91M-15.0%-$69.36M-37.4%-$26.09M+44.4%-$53.18M—-$53.85M+12.8%
$880K+2.8%$858K-0.8%$841K-3.9%$844K-6.9%$856K-9.7%
$10.29M+59.0%$10.73M+73.2%$9.06M+83.0%$7.35M+127%$6.47M+83.3%
-$60.14M-34.6%-$53.58M-16.5%-$59.55M+5.5%-$33.78M+22.6%-$44.67M+3.9%
$15K-94.0%$884K+189%$438K+165%$0-100%$248K-35.2%
-$110.86M-44,601%-$123.45M-40,244%-$438K-165%$0+100%-$248K+35.2%
$433K-98.7%$330K-97.2%$2.53M-39.2%$439.7M+1,157%$32.69M-84.0%
-$170.69M-1,293%-$176.58M-411%-$57.47M+2.6%$405.86M—-$12.25M-108%
-$60.16M-33.9%-$54.47M-17.6%-$59.99M+5.1%-$33.78M+22.8%-$44.91M+4.2%

FAQ

How much cash does Wave Life Sciences generate?
Wave Life Sciences (WVE) generated -$207.1M in operating cash flow over the trailing twelve months.
What is Wave Life Sciences's free cash flow?
After $1.3M of capital expenditures, Wave Life Sciences's free cash flow was -$208.4M over the trailing twelve months, down 5.2% year over year.
Where does Wave Life Sciences's cash flow data come from?
Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.